Author

S. M. Kitchen-Goosen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:metabolism & bioenergetics· 2 Assay:ATAC-seq· 1 Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1

Frequent Co-Authors

C. M. Krawczyk· 2 shared E. H. Ma· 2 shared I. Kaymak· 2 shared K. S. Williams· 2 shared L. M. DeCamp· 2 shared R. G. Jones· 2 shared A. Kupai· 1 shared B. K. Johnson· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. M. Krawczyk

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintJun 9, 2023

13C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8+ T cells

E. H. Ma, M. S. Dahabieh, L. M. DeCamp…·R. G. Jones

This study uses 13C-labeled metabolites to show CD8+ T cells switch from glutamine to acetate metabolism during infection.

DOI 10.1101/2023.06.09.544407

mousemetabolomics

𝕏 PostBluesky

ImmunologybioRxivPreprintAug 26, 2022

Ketolysis is a metabolic driver of CD8+ T cell effector function through histone acetylation

K. M. Luda, S. M. Kitchen-Goosen, E. H. Ma…·R. G. Jones

This study identifies ketone bodies as essential for CD8+ T cell metabolism and effector function through histone acetylation regulation.

DOI 10.1101/2022.08.26.505402

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 3, 2019

Direct therapeutic targeting of SWI/SNF induces epigenetic reprogramming and durable tumor regression in rhabdoid tumor

M. H. Chasse, B. K. Johnson, E. A. Boguslawski…·P. J. Grohar

This paper shows that targeting the SWI/SNF complex with mithramycin and its analogue EC8042 induces epigenetic reprogramming and durable tumor regression in rhabdoid tumors.

DOI 10.1101/861484

𝕏 PostBluesky